Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Vos

Showing results (571-580 of 604) with videos related to

Pageof 61
Sort By:
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 7, 2021
Cost Effectiveness of a CYP2C19 Genotype-Guided Strategy in Patients with Acute Myocardial Infarction: Results from the POPular Genetics TrialDaniel M F Claassens, Pim W M van Dorst, Gerrit J A Vos, et al.
Cardiovascular Research|July 1, 2016
Calmodulin/CaMKII inhibition improves intercellular communication and impulse propagation in the heart and is antiarrhythmic under conditions when fibrosis is absentHiroki Takanari, Vincent J A Bourgonje, Magda S C Fontes, et al.
Journal of Clinical Medicine|October 3, 2020
Rationale and Design of the Future Optimal Research and Care Evaluation in Patients with Acute Coronary Syndrome (FORCE-ACS) Registry: Towards "Personalized Medicine" in Daily Clinical PracticeDean R P P Chan Pin Yin, Gert-Jan A Vos, Niels M R van der Sangen, et al.
Circulation. Cardiovascular Interventions|March 16, 2021
Clopidogrel Versus Ticagrelor or Prasugrel After Primary Percutaneous Coronary Intervention According to CYP2C19 Genotype: A POPular Genetics SubanalysisDaniel M F Claassens, Thomas O Bergmeijer, Gerrit J A Vos, et al.
The New England Journal of Medicine|September 4, 2019
A Genotype-Guided Strategy for Oral P2Y<sub>12</sub> Inhibitors in Primary PCIDaniel M F Claassens, Gerrit J A Vos, Thomas O Bergmeijer, et al.
Vaccine|March 15, 2022
Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: A complementary tool to detect breakthrough infections after COVID-19 vaccination?Lotus L van den Hoogen, Gaby Smits, Cheyenne C E van Hagen, et al.
Heart Rhythm|November 27, 2012
Remodeling of the cardiac sodium channel, connexin43, and plakoglobin at the intercalated disk in patients with arrhythmogenic cardiomyopathyMaartje Noorman, Sara Hakim, Elise Kessler, et al.
ESC Heart Failure|October 10, 2018
Rationale and design of the EU-CERT-ICD prospective study: comparative effectiveness of prophylactic ICD implantationMarkus Zabel, Christian Sticherling, Rik Willems, et al.
International Journal of Cardiology|April 22, 2021
Clopidogrel in noncarriers of CYP2C19 loss-of-function alleles versus ticagrelor in elderly patients with acute coronary syndrome: A pre-specified sub analysis from the POPular Genetics and POPular Age trials CYP2C19 alleles in elderly patientsDaniel M F Claassens, Marieke E Gimbel, Thomas O Bergmeijer, et al.
Journal of Electrocardiology|September 19, 2019
Present criteria for prophylactic ICD implantation: Insights from the EU-CERT-ICD (Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope) projectMarkus Zabel, Simon Schlögl, Andrzej Lubinski, et al.
Pageof 61

Showing results (571-580 of 604) with videos related to

Sort By:
Pageof 61
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|September 7, 2021
Cost Effectiveness of a CYP2C19 Genotype-Guided Strategy in Patients with Acute Myocardial Infarction: Results from the POPular Genetics TrialDaniel M F Claassens, Pim W M van Dorst, Gerrit J A Vos, et al.
Cardiovascular Research|July 1, 2016
Calmodulin/CaMKII inhibition improves intercellular communication and impulse propagation in the heart and is antiarrhythmic under conditions when fibrosis is absentHiroki Takanari, Vincent J A Bourgonje, Magda S C Fontes, et al.
Journal of Clinical Medicine|October 3, 2020
Rationale and Design of the Future Optimal Research and Care Evaluation in Patients with Acute Coronary Syndrome (FORCE-ACS) Registry: Towards "Personalized Medicine" in Daily Clinical PracticeDean R P P Chan Pin Yin, Gert-Jan A Vos, Niels M R van der Sangen, et al.
Circulation. Cardiovascular Interventions|March 16, 2021
Clopidogrel Versus Ticagrelor or Prasugrel After Primary Percutaneous Coronary Intervention According to CYP2C19 Genotype: A POPular Genetics SubanalysisDaniel M F Claassens, Thomas O Bergmeijer, Gerrit J A Vos, et al.
The New England Journal of Medicine|September 4, 2019
A Genotype-Guided Strategy for Oral P2Y<sub>12</sub> Inhibitors in Primary PCIDaniel M F Claassens, Gerrit J A Vos, Thomas O Bergmeijer, et al.
Vaccine|March 15, 2022
Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: A complementary tool to detect breakthrough infections after COVID-19 vaccination?Lotus L van den Hoogen, Gaby Smits, Cheyenne C E van Hagen, et al.
Heart Rhythm|November 27, 2012
Remodeling of the cardiac sodium channel, connexin43, and plakoglobin at the intercalated disk in patients with arrhythmogenic cardiomyopathyMaartje Noorman, Sara Hakim, Elise Kessler, et al.
ESC Heart Failure|October 10, 2018
Rationale and design of the EU-CERT-ICD prospective study: comparative effectiveness of prophylactic ICD implantationMarkus Zabel, Christian Sticherling, Rik Willems, et al.
International Journal of Cardiology|April 22, 2021
Clopidogrel in noncarriers of CYP2C19 loss-of-function alleles versus ticagrelor in elderly patients with acute coronary syndrome: A pre-specified sub analysis from the POPular Genetics and POPular Age trials CYP2C19 alleles in elderly patientsDaniel M F Claassens, Marieke E Gimbel, Thomas O Bergmeijer, et al.
Journal of Electrocardiology|September 19, 2019
Present criteria for prophylactic ICD implantation: Insights from the EU-CERT-ICD (Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope) projectMarkus Zabel, Simon Schlögl, Andrzej Lubinski, et al.
Pageof 61